• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌单克隆抗体Ki-67反应性与分级及DNA流式细胞术的比较。

Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.

作者信息

Walker R A, Camplejohn R S

机构信息

Department of Pathology, Leicester Royal Infirmary, UK.

出版信息

Br J Cancer. 1988 Mar;57(3):281-3. doi: 10.1038/bjc.1988.60.

DOI:10.1038/bjc.1988.60
PMID:3355766
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246523/
Abstract

The reactivity of 95 breast carcinomas with the antibody Ki-67, which recognises a nuclear antigen in proliferating cells, has been assessed and compared to their histological grade and, for 47 tumours, DNA index and S-phase content. The effects of freezing and section handling on the stability of the nuclear antigen have been assessed. Evidence of nuclear staining was seen in 56% of carcinomas, with a range of positive cells from less than 1% to 60%. Cytoplasmic rather than nuclear staining was observed in 26% and 18% of carcinomas were negative. A significant correlation was observed between the presence of nuclear staining and poorer histological grade and higher S-phase content, and between the percentage of positive nuclei and S-phase content, but not grade. Three groups of carcinomas were identified: those in which Ki-67 reactivity, grade and S-phase content were similar; ones in which there was prominent nuclear reactivity with Ki-67 but low grade and S-phase content; and a group showing the converse. These patients will be followed to assess which of these three markers of proliferation is of greatest prognostic value.

摘要

对95例乳腺癌与Ki-67抗体的反应性进行了评估,该抗体可识别增殖细胞中的一种核抗原,并将其与组织学分级进行比较,对47例肿瘤还比较了DNA指数和S期含量。评估了冷冻和切片处理对核抗原稳定性的影响。56%的癌可见核染色证据,阳性细胞范围从不到1%至60%。26%的癌观察到细胞质而非核染色,18%的癌为阴性。核染色的存在与较差的组织学分级和较高的S期含量之间,以及阳性核百分比与S期含量之间存在显著相关性,但与分级无关。确定了三组癌:Ki-67反应性、分级和S期含量相似的癌;Ki-67核反应性突出但分级和S期含量低的癌;以及呈现相反情况的一组癌。将对这些患者进行随访,以评估这三种增殖标志物中哪一种具有最大的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e5/2246523/d902079ec898/brjcancer00137-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e5/2246523/3185a264cc1e/brjcancer00137-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e5/2246523/d902079ec898/brjcancer00137-0046-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e5/2246523/3185a264cc1e/brjcancer00137-0046-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0e5/2246523/d902079ec898/brjcancer00137-0046-b.jpg

相似文献

1
Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas.乳腺癌单克隆抗体Ki-67反应性与分级及DNA流式细胞术的比较。
Br J Cancer. 1988 Mar;57(3):281-3. doi: 10.1038/bjc.1988.60.
2
Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.通过图像分析和流式细胞术对乳腺癌增殖和DNA含量的比较评估
Am J Pathol. 1990 May;136(5):1115-24.
3
Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.乳腺癌细胞动力学:通过单克隆抗体Ki-67免疫细胞化学测定生长分数及其与流式细胞术S期以及肿瘤侵袭性某些特征的相关性。
Anticancer Res. 1991 Nov-Dec;11(6):2015-21.
4
Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.乳腺癌中的定量DNA分析与增殖。图像分析与流式细胞术的比较。
Pathol Res Pract. 1992 Jun;188(4-5):428-32. doi: 10.1016/S0344-0338(11)80032-4.
5
Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.抗增殖细胞核抗原单克隆抗体的细胞周期相关染色模式。与溴脱氧尿苷标记和Ki-67染色的比较。
Am J Pathol. 1991 May;138(5):1165-72.
6
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.免疫增殖标志物Ki-S2作为淋巴结阴性乳腺癌的预后指标
J Natl Cancer Inst. 1999 Feb 3;91(3):271-8. doi: 10.1093/jnci/91.3.271.
7
Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.流式细胞术与乳腺癌中Ki67标记指数的比较:181例病例的前瞻性评估
Anticancer Res. 2002 Jan-Feb;22(1A):295-8.
8
Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.软组织病变中的增殖标志物Ki-67和p105。与DNA流式细胞术特征的相关性。
Am J Pathol. 1990 Dec;137(6):1491-500.
9
Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.MIB-1与其他增殖标志物之间的相关性:MIB-1临界值的临床意义。
Cancer. 2002 Apr 15;94(8):2151-9. doi: 10.1002/cncr.10458.
10
MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.中级别恶性淋巴瘤中的MIB-1、Ki67和增殖细胞核抗原评分及DNA流式细胞术
J Clin Pathol. 1994 Jan;47(1):18-22. doi: 10.1136/jcp.47.1.18.

引用本文的文献

1
Assessing the efficacy of molecularly targeted agents on cell line-based platforms by using system identification.基于系统辨识评估基于细胞系的平台上分子靶向药物的疗效。
BMC Genomics. 2012;13 Suppl 6(Suppl 6):S11. doi: 10.1186/1471-2164-13-S6-S11. Epub 2012 Oct 26.
2
Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer.p53和Ki67表达在非小细胞肺癌患者纤维支气管活检中的预后价值
Multidiscip Respir Med. 2012 Sep 14;7(1):29. doi: 10.1186/2049-6958-7-29.
3
Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

本文引用的文献

1
Cell proliferation and its relationship to clinical features and relapse in breast cancers.
Cancer. 1981 Aug 15;48(4):974-9. doi: 10.1002/1097-0142(19810815)48:4<974::aid-cncr2820480420>3.0.co;2-#.
2
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.癌症研究运动(国王学院/剑桥早期乳腺癌试验:临床病理方面)
Br J Cancer. 1982 May;45(5):655-69. doi: 10.1038/bjc.1982.106.
3
Prediction of early course of breast carcinoma by thymidine labeling.通过胸腺嘧啶核苷标记预测乳腺癌的早期病程。
通过MIB1检测的细胞增殖与乳腺癌手术时机
Br J Cancer. 1998 May;77(9):1502-7. doi: 10.1038/bjc.1998.247.
4
Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.人眼外病变中增殖细胞核抗原和Ki-67免疫染色的比较。
Graefes Arch Clin Exp Ophthalmol. 1997 Dec;235(12):767-72. doi: 10.1007/BF02332861.
5
The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.Ki-67染色指数与复发性无功能垂体腺瘤肿瘤倍增时间的相关性
Acta Neurochir (Wien). 1996;138(12):1449-55. doi: 10.1007/BF01411125.
6
Breast carcinomas occurring in young women (< 35 years) are different.发生在年轻女性(<35岁)中的乳腺癌有所不同。
Br J Cancer. 1996 Dec;74(11):1796-800. doi: 10.1038/bjc.1996.632.
7
The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.肿瘤细胞增殖在食管鳞状细胞癌中的预后意义。
Br J Cancer. 1996 Oct;74(7):1012-6. doi: 10.1038/bjc.1996.482.
8
Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.人乳腺癌中MIB-1增殖指数与S期细胞比例的比较。
Br J Cancer. 1996 Mar;73(5):640-3. doi: 10.1038/bjc.1996.111.
9
Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.人肾细胞癌的增殖异质性与ras基因点突变的发生率
J Cancer Res Clin Oncol. 1996;122(4):207-13. doi: 10.1007/BF01209647.
10
Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.他莫昔芬对人乳腺肿瘤中Ki67标记指数的影响及其与雌激素和孕激素受体状态的关系。
Br J Cancer. 1993 Mar;67(3):606-11. doi: 10.1038/bjc.1993.111.
Cancer. 1983 May 15;51(10):1879-86. doi: 10.1002/1097-0142(19830515)51:10<1879::aid-cncr2820511021>3.0.co;2-9.
4
The long-term prognostic significance of the thymidine labelling index in breast cancer.乳腺癌中胸苷标记指数的长期预后意义。
Int J Cancer. 1984 Apr 15;33(4):441-5. doi: 10.1002/ijc.2910330404.
5
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.使用流式细胞术分析石蜡包埋病理材料细胞DNA含量的方法。
J Histochem Cytochem. 1983 Nov;31(11):1333-5. doi: 10.1177/31.11.6619538.
6
Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry.通过DNA流式细胞术分析原发性和转移性人类实体瘤的增殖特征
Cytometry. 1984 Nov;5(6):629-35. doi: 10.1002/cyto.990050612.
7
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.产生一种与细胞增殖相关的人类核抗原有反应性的小鼠单克隆抗体。
Int J Cancer. 1983 Jan 15;31(1):13-20. doi: 10.1002/ijc.2910310104.
8
DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors.
J Pathol. 1986 Sep;150(1):37-42. doi: 10.1002/path.1711500107.
9
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
J Clin Pathol. 1986 Sep;39(9):977-80. doi: 10.1136/jcp.39.9.977.
10
The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma.
Cancer. 1987 Jan 1;59(1):83-8. doi: 10.1002/1097-0142(19870101)59:1<83::aid-cncr2820590119>3.0.co;2-i.